Form 4: Guardian Pharmacy CEO Converts Class B to Class A Stock
Insider Transaction Report
Fred Burke, CEO of Guardian Pharmacy Services, converted 1.3 million Class B shares into Class A common stock as part of a pre-scheduled plan.
Summary
- Fred Burke, a Director, President, and Chief Executive Officer of Guardian Pharmacy Services, Inc. (GRDN), reported a change in beneficial ownership.
- On September 27, 2025, Burke's 1,298,826 shares of Class B common stock automatically converted into an equal number of Class A common stock shares.
- This conversion is a one-for-one exchange, as stipulated by the Issuer's Amended and Restated Certificate of Incorporation.
- Following this transaction, Burke beneficially owns 1,711,845 shares of Class A Common Stock.
- Burke's derivative beneficial ownership of Class B Common Stock decreased by 1,298,826 shares, resulting in 2,597,651 shares remaining.
Sentiment
Score: 5
Explanation: The filing reports a routine, pre-scheduled, and automatic conversion of stock by an insider, which is a neutral event with no immediate positive or negative implications for the company's operational or financial performance.
Positives
- The conversion mechanism is transparent and pre-defined within the company's Amended and Restated Certificate of Incorporation.
- The conversion of Class B to Class A common stock can potentially increase the liquidity and trading volume of Class A shares over time.
Future Outlook
The remaining shares of Class B common stock held by the reporting person are scheduled to automatically convert into Class A common stock in substantially equal tranches on March 28, 2026, and September 27, 2026, as per the company's Amended and Restated Certificate of Incorporation.
Industry Context
This filing is a routine insider transaction report specific to Guardian Pharmacy Services, Inc. and does not directly reflect broader industry trends. It pertains to the internal capital structure and insider holdings of the company.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Stock Conversion Mechanism | The automatic one-for-one conversion of Class B common stock to Class A common stock is mandated by the Issuer's Amended and Restated Certificate of Incorporation. | N/A (ongoing mechanism) | This mechanism provides a structured approach to simplify the company's capital structure over time, potentially enhancing transparency and liquidity for Class A shareholders. |
Stakeholder Impact
- Shareholders: The conversion increases the number of Class A common shares outstanding, potentially improving liquidity for Class A shareholders over time.
- Management: The reporting person's ownership structure shifts towards Class A common stock, aligning with the company's long-term capital structure strategy.
Next Steps
- Further automatic conversions of Class B common stock to Class A common stock are scheduled for March 28, 2026, and September 27, 2026.
Key Dates
| Date | Description |
|---|---|
| 09/27/2025 | Date of the reported transaction, where 1,298,826 shares of Class B common stock converted to Class A common stock. |
| 03/28/2026 | Future date for another tranche of automatic Class B to Class A common stock conversion. |
| 09/27/2026 | Future date for the final tranche of automatic Class B to Class A common stock conversion. |
| 09/30/2025 | Date the Form 4 was signed by the attorney-in-fact for the reporting person. |
Keywords
Guardian Pharmacy Services, GRDN, Fred Burke, SEC Form 4, Insider Transaction, Stock Conversion, Class A Common Stock, Class B Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.